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Introduction
Haemolytic uraemic syndrome (HUS) classically presents as a post-diarrhoeal disease, 
and is often associated with Escherichia coli (O157:H7) infection. However, the relative 
incidence of HUS associated with invasive pneumococcal infection may be underestimated 
due to lack of awareness,1 and the incidence may be increasing.2 Pneumococcal HUS is 
characterised by T-antigen activation, whereby the enzyme neuraminidase produced by 
the bacteria cleaves N-acetylneuraminic acid from the glycoproteins on the cell membrane 
of the red blood cells (RBCs) and glomeruli and exposes the Thomsen-Friedenreich 
antigen (T-antigen). This desialylation of glycoprotein is thought to be important in the 
pathogenesis of HUS.3 Pneumococcal HUS is associated with significant mortality and 
morbidity in Caucasians.2 This report is of a retrospective review of all patients with a 
diagnosis of HUS made between January 2006 and December 2008 at the Haematology 
Division, Department of Pathology, Queen Mary Hospital, Hong Kong. Data on clinical 
manifestations, laboratory findings and follow-up status were collected from the patients’ 
medical records and compared with reports in the literature. 
 Haemolytic uraemic syndrome was defined by a triad of microangiopathic haemolysis, 
thrombocytopaenia, and acute renal impairment. Acute disseminated intravascular 
coagulation was excluded by the absence of a significantly raised D-dimer level (<8 mg/L). 
Acute renal impairment was determined by a serum creatinine level above the age-specific 
reference range in a patient with no known history of renal disease. Neurological signs 
should be absent unless there was documented evidence of central nervous system 
infection. T-antigen activation on RBCs was documented by Arachis hypogaea (peanut) 
lectin agglutination. 
Case report
Five patients with HUS were identified, and all were children with invasive Streptococcus 
pneumoniae respiratory infection (Table). There were two boys and three girls. Their 
median age was 3 years (range, 2-4 years). Haemolytic uraemic syndrome was diagnosed 
between 3 days and 11 days after the onset of febrile illness for all patients. Bacteriology 
was confirmed by positive blood and/or pleural fluid culture (Table). Only one of the 
isolates was sensitive to penicillin. Serotyping results were available for four patients: 
type 14 (n=2), type 3 (n=1), type 19A (n=1). Four of the five patients developed empyema 
requiring decortication. Two patients received ventilatory support. None of the patients 
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Haemolytic	uraemic	syndrome	is	an	important	cause	of	acute	renal	impairment	in	childhood.	
We	review	the	incidence,	and	clinical	and	laboratory	features	of	haemolytic	uraemic	syndrome	
in	a	Chinese	population.	Five	patients	were	identified	from	2006	to	2008.	All	patients	were	
young	 children	with	 associated	 invasive	 Streptococcus pneumoniae	 pulmonary	 infection.	
Serotypes	 3,	 14,	 and	 19A	 were	 confirmed	 in	 four	 patients.	 The	 classical	 post-diarrhoeal	
form	associated	with	Escherichia coli	(O157:H7)	infection	was	not	seen.	One	patient	died	of	
acute	 respiratory	 failure.	Streptococcus pneumoniae	 infection,	 as	 an	associated	condition	
in	haemolytic	uraemic	syndrome,	is	 important	and	relatively	common	in	Chinese	patients,	
especially	among	children.	The	acute	clinical	picture	is	similar	to	that	reported	in	the	western	
literature,	 except	 for	 an	 uncommon	 association	with	meningitis.	 The	medium-term	 renal	
outcome	of	 the	Chinese	 population	 appears	 to	 be	more	 favourable	 than	 the	Caucasians.	
Widespread	vaccination	against	Streptococcus pneumoniae	may	have	resulted	in	changes	in	
bacterial	epidemiology	and	clinicians	should	be	continuously	aware	of	this	severe	disease.	
The	 use	 of	washed	blood	 components	 for	 transfusion	 in	 the	 acute	 stage	 requires	 further	
study.
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* Onset of pneumococcal HUS after initial febrile illness
† Reference paediatric range (10-60 μmol/L)
‡ Reference paediatric range (95-165 g/L)
§ Reference paediatric range (150-400 x 109 /L)
¶ All patients received washed red blood cells and plasma-reduced platelet concentrates after the diagnosis of pneumococcal HUS
TABLE. Clinical features, laboratory findings and outcomes of patients with haemolytic uraemic syndrome (HUS)
Patient 
No.
Sex/age 
(years)
Onset* 
(days)
Respiratory 
disease
Respiratory 
intervention
Peak serum 
creatinine 
(μmol/L)†
Dialysis Nadir 
haemoglobin 
(g/L)‡
Nadir 
platelet 
count 
(x 109 /L)§
T-antigen 
activation
Transfusion¶ 
(units 
transfused)
Follow-up 
duration 
(months)
Serum creatinine 
and blood cell 
counts at last 
follow-up
Pneumococcal 
vaccination 
history
Streptococcus 
pneumoniae 
serotype
Bacterial 
culture 
from 
blood
Bacterial 
culture 
from pleural 
fluid
Antibiotic sensitivity
1 M/4 10 Pneumonia, 
empyema, 
pleural effusion
Decortication 268 No 13 9 Yes Red blood cells 
(7)
36 Normal Nil Not tested Positive Negative Resistant to penicillin, 
sensitive to ceftriaxone 
2 F/2 11 Pneumonia, 
pleural effusion
Nil 756 Continuous 
ambulatory 
peritoneal dialysis for 
2 weeks
55 4 Yes Red blood cells 
(4), platelets (1)
27 Normal Nil 3 Positive Negative Sensitive to penicillin, 
cefotaxime
3 F/3 3 Pneumonia, 
empyema
Decortication, 
mechanical 
ventilation
368 No 44 9 Yes Red blood cells 
(3), platelets (3)
18 Normal Nil 19A Positive Positive Resistant to penicillin, 
sensitive to ceftriaxone, 
vancomycin 
4 M/3 10 Pneumonia, 
empyema, 
pleural effusion
Decortication 101 No 49 8 Yes Red blood cells 
(3), platelets (1)
18 Normal Nil 14 Negative Positive Moderately sensitive to 
penicillin, sensitive to 
cefotaxime, vancomycin
5 F/3 5 Pneumonia, 
empyema, 
pleural effusion
Mechanical 
ventilation
130 No 46 6 Yes Red blood cells 
(3), platelets (3)
Died 1 
day after 
admission
Not applicable Prevenar (one 
dose)
14 Positive Positive Moderately resistant to 
penicillin, sensitive to 
cefotaxime, vancomycin
溶血性尿毒綜合徵是幼年期急性腎衰竭的主因之一。本文回顧華人溶
血性尿毒綜合徵的發病率、其臨床和實驗室檢查特徵。2006至2008
年期間，五名受入侵性肺炎鏈球菌感染的病童中，四人確診為血清3
型、14型和19A型。所有患者並未出現與上述綜合徵相關的腹瀉和大
腸桿菌O157：H7感染。一名病童因急性呼吸衰竭死亡。與溶血性尿
毒綜合徵息息相關的肺炎鏈球菌感染尤其多發生在華籍兒童，不可忽
視。這種疾病的急性臨床症狀與西方文獻相若。雖然華籍患者較大機
會感染不常見的腦膜炎，但其腎功能的中期康復進度似乎較西方患者
理想。針對肺炎鏈球菌的廣泛疫苗接種或會改變細菌的流行病學，醫
生應持續監察這種嚴重疾病。至於在急性發病期間以血液洗滌方式輸
血的做法，還需作進一步研究。
五名患有溶血性尿毒綜合徵的華籍兒童中常
見併發的入侵性肺炎鏈球菌感染
150-400 x 109 /L]), respectively. The clotting profile was 
deranged in all patients, as reflected by prolonged 
activated partial thromboplastin time (range, 56.5-
109.0 seconds [reference range, 25.9-33.7 seconds]) 
and normal-to-mildly prolonged prothrombin time 
(range, 11.5-20.4 seconds [reference range, 11.3-13.5 
seconds]). Fibrinogen was elevated in all patients 
(range, 4.14-7.66 g/L [reference range, 1.46-3.38 
g/L]), partially masking the coagulation defects. In 
keeping with the clinical picture, evidence of frank 
disseminated intravascular coagulation was not 
detected with D-dimer assay at presentation (<8 mg/L 
in all patients). 
 T-antigen activation on RBCs was documented 
in all patients. Direct antiglobulin test was positive 
for complement with or without immunoglobulin in 
four patients. All patients received RBC transfusion. 
Four patients received platelet transfusion for 
prophylaxis or to cover invasive procedures. Washed 
RBCs and plasma-reduced platelet concentrates were 
transfused, except for one patient who was transfused 
before a diagnosis of HUS was made. This patient 
had respiratory failure requiring cardiopulmonary 
resuscitation soon after admission, with an associated 
rapid drop in haemoglobin level and platelet count. 
She received urgent transfusion with unwashed RBCs 
and ordinary platelet concentrates. She developed 
disseminated intravascular coagulation and died 
of refractory septicaemic shock and multi-organ 
failure a few hours later. This patient had previously 
received one dose of pneumococcal vaccine. The 
other four patients had not been vaccinated against 
pneumococcus.
had evidence of meningitis. 
 All patients had impaired renal function as 
evidenced by a raised serum creatinine level (range, 
101-756 μmol/L [reference range, 10-60 μmol/L]). Two 
patients developed oliguria, one of whom required 
dialysis for 2 weeks for anuria, fluid retention, and 
rapidly deteriorating renal function. Profound 
anaemia and thrombocytopaenia were consistent 
findings. Peripheral blood smear examination 
revealed RBC fragmentation in all patients, which 
provided the first clue to the diagnosis (Fig). None 
of the patients had significant bleeding. The mean 
nadir haemoglobin level and platelet count was 41 
g/L (range, 13-55 g/L [reference range, 95-165 g/L]) 
and 7 x 109 /L (range, 4-9 x 109 /L [reference range, 
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 All four surviving patients had normal serum 
creatinine (<60 mmol/L), haemoglobin (>100 g/L), and 
platelet (>150 x 109 /L) levels, and no hypertension, 
proteinuria, or haematuria during a median follow-
up of 31 months (range, 24-48 months). 
Discussion
Haemolytic uraemic syndrome in Chinese patients 
is commonly associated with invasive S pneumoniae 
infection. This complication appears to be restricted to 
the paediatric age-group and is uncommon in adults, 
probably because T-antigen activation usually occurs 
in the paediatric age-group. Indeed, all five patients 
with HUS in this report were young and had severe 
pulmonary S pneumoniae infection. Observation of 
microangiopathic haemolysis at peripheral blood 
smear examination and demonstration of T-antigen 
activation on RBCs provide strong support for the 
diagnosis of HUS. The acute clinical and laboratory 
findings in terms of disease onset, pulmonary, renal 
and haematological manifestations of the patients 
in this report were similar to pneumococcal HUS 
reported in both Chinese and Caucasian series,2,4 
with the exception of an uncommon association with 
meningitis in Chinese patients. A study of 43 patients 
from the UK reported an acute mortality rate of 9%, 
with three of four deaths related to central nervous 
system involvement.2 
 No documented case of E coli (O157:H7) 
infection and associated HUS has been seen at 
Queen Mary Hospital from 2003 to 2008. This 
confirms findings from other reports of Chinese 
patients,4,5 but contrasts with reports from western 
countries where pneumococcal HUS constitutes 5% 
or less of all HUS,6-8 although an increasing trend has 
been observed.2 The marked difference in relative 
prevalence of E coli– and S pneumoniae–induced HUS 
among different ethnic groups is intriguing, and may 
point to underlying genetic and/or environmental 
factors affecting disease susceptibility. 
 In the largest reported series of pneumococcal 
HUS, renal morbidity at a median follow-up of 9 
Patient 
No.
Sex/age 
(years)
Onset* 
(days)
Respiratory 
disease
Respiratory 
intervention
Peak serum 
creatinine 
(μmol/L)†
Dialysis Nadir 
haemoglobin 
(g/L)‡
Nadir 
platelet 
count 
(x 109 /L)§
T-antigen 
activation
Transfusion¶ 
(units 
transfused)
Follow-up 
duration 
(months)
Serum creatinine 
and blood cell 
counts at last 
follow-up
Pneumococcal 
vaccination 
history
Streptococcus 
pneumoniae 
serotype
Bacterial 
culture 
from 
blood
Bacterial 
culture 
from pleural 
fluid
Antibiotic sensitivity
1 M/4 10 Pneumonia, 
empyema, 
pleural effusion
Decortication 268 No 13 9 Yes Red blood cells 
(7)
36 Normal Nil Not tested Positive Negative Resistant to penicillin, 
sensitive to ceftriaxone 
2 F/2 11 Pneumonia, 
pleural effusion
Nil 756 Continuous 
ambulatory 
peritoneal dialysis for 
2 weeks
55 4 Yes Red blood cells 
(4), platelets (1)
27 Normal Nil 3 Positive Negative Sensitive to penicillin, 
cefotaxime
3 F/3 3 Pneumonia, 
empyema
Decortication, 
mechanical 
ventilation
368 No 44 9 Yes Red blood cells 
(3), platelets (3)
18 Normal Nil 19A Positive Positive Resistant to penicillin, 
sensitive to ceftriaxone, 
vancomycin 
4 M/3 10 Pneumonia, 
empyema, 
pleural effusion
Decortication 101 No 49 8 Yes Red blood cells 
(3), platelets (1)
18 Normal Nil 14 Negative Positive Moderately sensitive to 
penicillin, sensitive to 
cefotaxime, vancomycin
5 F/3 5 Pneumonia, 
empyema, 
pleural effusion
Mechanical 
ventilation
130 No 46 6 Yes Red blood cells 
(3), platelets (3)
Died 1 
day after 
admission
Not applicable Prevenar (one 
dose)
14 Positive Positive Moderately resistant to 
penicillin, sensitive to 
cefotaxime, vancomycin
FIG. Peripheral blood smear of patient 5 showing red blood cell fragments and absence 
of platelets.  A nucleated red cell is depicted in the centre of the picture (Wright stain; 
original magnification, x 100)
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months was considerable,2 with 10 of 35 patients 
showing evidence of renal dysfunction as evidenced 
by raised serum creatinine level, proteinuria, 
and/or hypertension. In contrast, the prognosis 
for renal recovery appears to be favourable for 
Chinese patients. Two Chinese studies reported 
complete renal recovery with no evidence of chronic 
sequelae.4,5 The surviving patients in this series 
also had a normal serum creatinine level with no 
hypertension or proteinuria at a median follow-up 
of 31 months. Longer follow-up will confirm whether 
this renal status remains stable. 
 Different serotypes of neuraminidase-
producing S pneumoniae have been implicated in 
pneumococcal HUS. Serotype 14 is seen in most 
series but the most prevalent serotype varies among 
populations.2,4,9 Interestingly, the widely used 7-
valent pneumococcal conjugate vaccine (serotype 
4, 6B, 9V, 14, 18C, 19F, 23F) does not include most 
of the serotypes isolated in pneumococcal HUS in 
a recent UK study.2 In particular, serotypes 3 and 
19A are not covered. Serotype 19A was the most 
prevalent in the UK study,2 reflecting its increasing 
prevalence in the paediatric age-group since the 
introduction of the 7-valent vaccine in the US.10 
Serotype 19A is also not covered by the 9- or 11-
valent pneumococcal vaccines, and pneumococcal 
HUS associated with serotype 19A is increasingly 
being reported.11,12 The same epidemiological change 
in pneumococcal infection has been observed in 
Chinese populations. A large epidemiological study 
of serotype distribution of invasive S pneumoniae 
isolates collected from children in Hong Kong 
between 1995 and 2001 showed that serotypes 6B, 9V, 
14, 18C, 19F and 23F together constituted 90% of all 
isolates.13 As serotype 19A was not detected in any 
isolate, good protection from the 7-valent vaccine 
could be expected. However, serotype 19A has 
recently become more prevalent in China in children 
younger than 5 years.14 The data from this report 
showed that serotypes 3 and 19A were present among 
patients with pneumococcal HUS. A study from 
Taiwan also detected the occurrence of serotype 3 in 
patients with pneumococcal HUS.9 A pneumococcal 
vaccination programme using the 7-valent vaccine 
has been implemented in many countries, including 
Hong Kong. Post-vaccine surveillance is therefore 
important to monitor any increase of invasive S 
pneumoniae infection and pneumococcal HUS due to 
infection by serotypes not covered by the vaccine.
 T-antigen activation is demonstrable in all 
patients with pneumococcal HUS.2,9 As anti-T 
1. Copelovitch L, Kaplan BS. Streptococcus pneumoniae-
associated hemolytic uremic syndrome. Pediatr Nephrol 
2008;23:1951-6.
2. Waters AM, Kerecuk L, Luk D, et al. Hemolytic uremic 
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